Skip to content

About us

Our mission

Unlocking the power of cancer immmunotherapy

Our biotech company is at the forefront of developing innovative cancer therapies. Our approach centers on unlocking the potential of the immune system to specifically target and eliminate cancer cells in difficult to treat tumors. By integrating cutting-edge research, we aim to enhance the body’s immune response to effectively combat cancer cells. Our mission is to revolutionize cancer care and provide patients with new, life-changing therapeutic options.

Meet the team

Management

Jeremy Bastid
PharmD, PhD
CEO and cofounder
Jeremy Bastid holds a PharmD degree and a PhD in oncology. He is also the CEO of OREGA Biotech, Chief Development Officer and Medical Director of ORPHELIA Pharma and R&D Director of OCTALFA (company). He is President of The White Bird (holding).
Julien Alberici
Chairman
Julien Alberici is the CEO of OCTALFA, a family-owned holding company specializing in Life Sciences, and the Dominique & Tom Alberici-Octalfa Corporate Foundation. Octalfa is a cofounder of Ventuno Biotech.
Nathalie Bonnefoy
PhD
Cofounder & scientific advisor
Nathalie Bonnefoy, PhD in Immunology, is Research Director at INSERM 1194 and Deputy Director at the Institut de Recherche en Cancérologie de Montpellier. Nathalie Bonnefoy is author of more than 80 scientific peer reviewed publications and 10 patents.

Board of directors

Jeremy Bastid
PharmD, PhD
CEO and cofounder
Jeremy Bastid holds a PharmD degree and a PhD in oncology. He is also the CEO of OREGA Biotech, Chief Development Officer and Medical Director of ORPHELIA Pharma and R&D Director of OCTALFA (company). He is President of The White Bird (holding).
Julien Alberici
Chairman
Julien Alberici is the CEO of OCTALFA, a family-owned holding company specializing in Life Sciences, and the Dominique & Tom Alberici-Octalfa Corporate Foundation. Octalfa is a cofounder of Ventuno Biotech.
Gilles Alberici
PhD
Gilles Alberici holds a PharmD degree and a PhD in Immunology. He founded and managed several biopharmaceutical and biotechnology companies in various therapeutic areas, notably immunosuppression and transplantation, acute leukemias and rare diseases.

Scientific team

Scientific Advisory Board

Nathalie Bonnefoy
PhD
Cofounder & scientific advisor
Nathalie Bonnefoy, PhD in Immunology, is Research Director at INSERM 1194 and Deputy Director at the Institut de Recherche en Cancérologie de Montpellier. Nathalie Bonnefoy is author of more than 80 scientific peer reviewed publications and 10 patents.
Developing the next wave
of immunotherapies

Follow us on

Linkedin
COmpany
Contact

Ventuno Biotech
15 chemin du Saquin, bât. G – 69130 Ecully

contact@ventuno-biotech.com
+33 4 37 49 87 20

© 2025 Ventuno Biotech – Design by Back To Back